Our Authors
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialisation of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.2 Articles
With a portfolio representing a continuum of activities spanning from prescription drugs and consumer healthcare products to dermo-cosmetics, Pierre Fabre is the second largest dermo-cosmetics laboratory in the world, the second largest private French pharmaceutical group and the market leader in France for products sold over the counter in pharmacies. Its portfolio includes several global brands and franchises, such as Pierre Fabre Oncologie.2 Articles
Prof Bogda Koczwara is a medical oncologist and a senior staff specialist at the Flinders Centre for Innovation in Cancer. Prof Koczwara completed her oncology training at the Roswell Park Cancer Institute in Buffalo, New York and received a Master in Bioethics degree from the Monash University. Her clinical interests revolve around management of breast cancer, cancer survivorship, psycho-oncology and supportive care as well as health services development, integration with primary care and cancer education for health care professionals. Prof Koczwara's interest in needs of cancer survivors have led to her developing a Survivorship Program at Flinders that aims to promote excellence in clinical care and research relating to the needs of cancer survivors. She is the National Breast Cancer Foundation Practitioner Fellow working on the chronic disease management after cancer.2 Articles
Dr Diana Adams is a Consultant Medical Oncologist at Macarthur Cancer Therapy Centre, Sydney South West Area Health Service.2 Articles
Associate Professor Mirette Saad is a Consultant Chemical Pathologist and the National Clinical Director of Molecular Genetic Pathology at Australian Clinical Labs. At Clinical Labs, A/Prof Mirette Saad leads the Molecular Genetic testing for Non-Invasive Prenatal Testing (NIPT), carrier screening, personalised drug therapy and cancer. She is a member of the RCPA Chemical Pathology Advisory Committee and a Chair of precision medicine services at Australian Clinical Labs.2 Articles
Fran Boyle is a Medical Oncologist at North Sydney’s Mater Hospital, where she is Director of the Patricia Ritchie Centre for Cancer Care and Research, and Professor of Medical Oncology. She has been involved in research and teaching in communication in health care for the past 20 years, and is currently Director of the Pam McLean Centre in the Sydney Medical School. Understanding professional burnout, and its relationship to empathy, teamwork and communication, has been a focus for the Pam McLean team. The more so as they find themselves trying to be balanced during crazy times with COVID.2 Articles
Professor Paul Grundy, Professor of Pediatrics and Oncology, Department of Pediatrics, University of Alberta, and Expert Lead, Pediatric, Adolescent and Young Adult Oncology, Canadian Partnership Against Cancer. His research career has focussed on Wilms tumour of the kidney, spanning the spectrum from basic molecular biology, to translational research to clinical trials.1 Articles
Fabio Martinelli, MD is an attending physician in the Department of Gynecologic Oncology at IRCCS Foundation - National Cancer Institute of Milan –Italy since 2012, when he graduated residency in Obstetrics and Gynecology from the University of Milan. During his training attended at The University of Texas MD Anderson Cancer Center - Gynecologic Oncology and Reproductive Medicine Department, at the Department of Gynaecology and Gynaecological Oncology of Kliniken-Essen-Mitte and at the Universidad Autonoma of Madrid.1 Articles
Chief Executive Officer of the Australia New Zealand Gynaecological Oncology Group. This group of over 750 clinical trial researchers has been identified as one of the top three trials groups in gynaecological cancer in the world. The Group is committed to excellence, has a genuinely collaborative culture and respected leadership.1 Articles
Teenage and Young Adult Researcher and Patient Engagement lead, National Cancer Research Institute Teenage, Young Adult and Germ Cell Clinical Studies Group; University College London Hospitals NHS Foundation Trust; BRIGHTLIGHT1 Articles